Globant (GLOB) Competitors

IQVIA (NYSE:IQV) and Globant (NYSE:GLOB) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, earnings, risk, valuation, institutional ownership, media sentiment, dividends, analyst recommendations and community ranking.

Which has higher valuation & earnings, IQV or GLOB?

IQVIA has higher revenue and earnings than Globant. IQVIA is trading at a lower price-to-earnings ratio than Globant, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IQVIA	$14.98B	2.33	$1.36B	$7.62	25.29
Globant	$2.10B	4.18	$158.54M	$3.83	53.08

Is IQV or GLOB more profitable?

IQVIA has a net margin of 9.17% compared to Globant's net margin of 7.39%. IQVIA's return on equity of 28.17% beat Globant's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
IQVIA	9.17%	28.17%	6.89%
Globant	7.39%	11.68%	8.05%

Does the MarketBeat Community favor IQV or GLOB?

IQVIA received 278 more outperform votes than Globant when rated by MarketBeat users. Likewise, 68.21% of users gave IQVIA an outperform vote while only 60.28% of users gave Globant an outperform vote.

Company	Underperform	Outperform
IQVIA	Outperform Votes 665 68.21%	Underperform Votes 310 31.79%
Globant	Outperform Votes 387 60.28%	Underperform Votes 255 39.72%

Do analysts rate IQV or GLOB?

IQVIA currently has a consensus price target of $259.13, suggesting a potential upside of 34.48%. Globant has a consensus price target of $228.50, suggesting a potential upside of 12.40%. Given IQVIA's stronger consensus rating and higher probable upside, research analysts clearly believe IQVIA is more favorable than Globant.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
IQVIA	0 Sell rating(s)	4 Hold rating(s)	14 Buy rating(s)	1 Strong Buy rating(s)	2.84
Globant	1 Sell rating(s)	6 Hold rating(s)	12 Buy rating(s)	0 Strong Buy rating(s)	2.58

Do institutionals and insiders believe in IQV or GLOB?

89.6% of IQVIA shares are owned by institutional investors. Comparatively, 91.6% of Globant shares are owned by institutional investors. 1.6% of IQVIA shares are owned by insiders. Comparatively, 2.7% of Globant shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Which has more risk and volatility, IQV or GLOB?

IQVIA has a beta of 1.51, suggesting that its share price is 51% more volatile than the S&P 500. Comparatively, Globant has a beta of 1.39, suggesting that its share price is 39% more volatile than the S&P 500.

Does the media prefer IQV or GLOB?

In the previous week, Globant had 21 more articles in the media than IQVIA. MarketBeat recorded 35 mentions for Globant and 14 mentions for IQVIA. IQVIA's average media sentiment score of 0.97 beat Globant's score of 0.59 indicating that IQVIA is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
IQVIA	10 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive
Globant	11 Very Positive mention(s)	5 Positive mention(s)	10 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

IQVIA beats Globant on 13 of the 19 factors compared between the two stocks.